David I Stuart
Overview
Explore the profile of David I Stuart including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
299
Citations
16865
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
31.
Bahar M, Nasta V, Fox H, Sherry L, Grehan K, Porta C, et al.
Commun Biol
. 2022 Nov;
5(1):1293.
PMID: 36434067
Strategies to prevent the recurrence of poliovirus (PV) after eradication may utilise non-infectious, recombinant virus-like particle (VLP) vaccines. Despite clear advantages over inactivated or attenuated virus vaccines, instability of VLPs...
32.
Huo J, Dijokaite-Guraliuc A, Nutalai R, Das R, Zhou D, Mentzer A, et al.
Cell Discov
. 2022 Nov;
8(1):119.
PMID: 36319620
No abstract available.
33.
Sherry L, Grehan K, Swanson J, Bahar M, Porta C, Fry E, et al.
Viruses
. 2022 Oct;
14(10).
PMID: 36298714
Following the success of global vaccination programmes using the live-attenuated oral and inactivated poliovirus vaccines (OPV and IPV), wild poliovirus (PV) is now only endemic in Afghanistan and Pakistan. However,...
34.
Shirasaki T, Feng H, Duyvesteyn H, Fusco W, McKnight K, Xie L, et al.
PLoS Pathog
. 2022 Aug;
18(8):e1010543.
PMID: 35969644
Although picornaviruses are conventionally considered 'nonenveloped', members of multiple picornaviral genera are released nonlytically from infected cells in extracellular vesicles. The mechanisms underlying this process are poorly understood. Here, we...
35.
Tuekprakhon A, Nutalai R, Dijokaite-Guraliuc A, Zhou D, Ginn H, Selvaraj M, et al.
Cell
. 2022 Jun;
185(14):2422-2433.e13.
PMID: 35772405
The Omicron lineage of SARS-CoV-2, which was first described in November 2021, spread rapidly to become globally dominant and has split into a number of sublineages. BA.1 dominated the initial...
36.
Wei J, Matthews P, Stoesser N, Diamond I, Studley R, Rourke E, et al.
Nat Commun
. 2022 Jun;
13(1):3748.
PMID: 35768431
Given high SARS-CoV-2 incidence, coupled with slow and inequitable vaccine roll-out in many settings, there is a need for evidence to underpin optimum vaccine deployment, aiming to maximise global population...
37.
Nutalai R, Zhou D, Tuekprakhon A, Ginn H, Supasa P, Liu C, et al.
Cell
. 2022 Jun;
185(12):2116-2131.e18.
PMID: 35662412
Highly transmissible Omicron variants of SARS-CoV-2 currently dominate globally. Here, we compare neutralization of Omicron BA.1, BA.1.1, and BA.2. BA.2 RBD has slightly higher ACE2 affinity than BA.1 and slightly...
38.
Shimmon G, Shah P, Fry E, Stuart D, Hawes P, Netherton C
Methods Mol Biol
. 2022 May;
2503:179-186.
PMID: 35575895
African swine fever virus is a cytolytic virus that leads to the apoptosis of both cultured cells and primary macrophages. Cell culture supernatants of virus-infected cells are routinely used for...
39.
Wei J, Pouwels K, Stoesser N, Matthews P, Diamond I, Studley R, et al.
Nat Med
. 2022 Feb;
28(5):1072-1082.
PMID: 35165453
Antibody responses are an important part of immunity after Coronavirus Disease 2019 (COVID-19) vaccination. However, antibody trajectories and the associated duration of protection after a second vaccine dose remain unclear....
40.
Dejnirattisai W, Huo J, Zhou D, Zahradnik J, Supasa P, Liu C, et al.
Cell
. 2022 Jan;
185(3):467-484.e15.
PMID: 35081335
On 24 November 2021, the sequence of a new SARS-CoV-2 viral isolate Omicron-B.1.1.529 was announced, containing far more mutations in Spike (S) than previously reported variants. Neutralization titers of Omicron...